Citadel Advisors - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,0000.0%16,500
+6.5%
0.00%
Q4 2021$5,000
-93.5%
15,500
-86.2%
0.00%
Q3 2021$77,000
-77.2%
112,257
-73.0%
0.00%
Q2 2021$338,000
+98.8%
416,235
+281.8%
0.00%
Q1 2021$170,000
+203.6%
109,024
+0.2%
0.00%
Q3 2020$56,000
+460.0%
108,800
+919.6%
0.00%
Q4 2018$10,00010,6710.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 5,555,555$1,656,0000.43%
NEA Management Company, LLC 14,451,147$4,306,0000.12%
Sarissa Capital Management LP 1,851,851$552,0000.05%
Ikarian Capital, LLC 1,289,130$384,0000.05%
FEDERATED HERMES, INC. 29,048,265$8,656,0000.02%
WealthTrust Axiom LLC 68,000$20,0000.01%
All Terrain Financial Advisors, LLC 15,000$4,0000.00%
GYL FINANCIAL SYNERGIES, LLC 34,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 124,056$37,0000.00%
McGuire Investment Group, LLC 15,000$4,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders